Skip to main content

Easter: FRSC deploys over 3,000 Marshals, sets up mobile courts

Easter: FRSC deploys over 3,000 Marshals, sets up mobile courts

Benue: FRSC Sector Commander warns personnel against bribery
By Marie-Therese Nanlong, Jos

Ahead of this year’s Easter celebration, the Federal Road Safety Corps, FRSC, Zone 4 Command comprising Plateau, Benue and Nasarawa States has called on all road users and transport fleet operators within the Zone to abide by traffic rules and regulations as well as the COVID-19 protocol during the Easter festive period or risk arrest and prosecution.

The Zonal Commanding Officer RS4, Assistant Corps Marshal Kayode OLAGUNJU, mni gave this warning in a release signed by the Acting Public Education Officer, Route Commander Olusegun Owoeye in Jos to herald the commencement in the Zone of the nationwide “EASTER SPECIAL PATROL OPERATION” with the aim of ensuring sanity and prevention of deaths and injuries on the road during the festive period.

ALSO READ: N544m Grass-cutting fraud: EFCC presents third witness against Babachir Lawal

The statement noted “The Command is poised to reduce road traffic crashes and fatalities as we celebrate Easter. The Zonal Commander has directed strict enforcement of traffic laws which include setting up Mobile Courts to try erring traffic offenders. The Commands are to promptly remove broken down vehicles and other forms of obstructions on the highways as well as ensure free flow of traffic through strategic traffic control and management. They are to also embark on massive education of motorists and other road users during the period slated between 31 March and 7 April 2021.”

The focus of the Operation includes tackling speeding and dangerous driving, overtaking violation, lane indiscipline, route violation, road obstructions, use of phone while driving, overloading, seat belt/child restraint use violations, passengers manifest violation, operation of mechanical deficient and rickety vehicles, latching and twist-locks violation, illegal use of the SPY Number Plates, driving under influence of alcohol and other intoxicants as well as non-adherence to the COVID-19 protocols among others.

ALSO READ: Babangida’s purported suspension from PDP: National body wades in

However, a total number of 3, 077 personnel comprising of 1,969 Regular and 1,108 Special Marshals are to be engaged in Traffic Management, Rescue Services, Public Education and Enforcement during the period and all operational vehicles and other logistics shall be fully deployed for maximum impacts. Mobile Courts will also be set up along major corridors in the Zone to try erring drivers and other road users.

All arrested violators will be arraigned before the Magistrates and they stand the risks of fines payment ranging between N2,000 and N50,000 depending on the nature of the offences and/or imprisonment terms ranging between two and six months as may be decided by the mobile courts.

Vanguard News Nigeria

The post Easter: FRSC deploys over 3,000 Marshals, sets up mobile courts appeared first on Vanguard News.


by Temisan Amoye via Vanguard News https://ift.tt/3wiZHog Best Known Member of the Cabinet Wikipedia
Labels:

Comments

Post a Comment

Popular posts from this blog

Effective Data Governance: IIM-Africa inks partnership deal with Data Management University

President/Chairman of the governing council of IIM-Africa, Dr. Oyedokun Oyewole has said that effective data governance strategy has become more essential for the survival and sustenance of government and businesses, especially with the sudden outbreak of COVID-19 Pandemic. Oyewole said there is the need to ensure that the right policies, processes, technology, and people are in place to effectively manage data while complying with legal and regulatory requirements. He said that as part of the IIM Africa’s commitments towards ensuring global best practices, it has entered into a long-term partnership with DataManagementU.com to bring the finest data management training to industries across Africa. READ ALSO:  COVID-19: Foreign affairs minister says first set of Nigerians abroad to be evacuated soon According to the IIM President, the alliance is expected to provide members of the Institute and other professionals across Africa, high standards, internationally-recognized learn...
Post a Comment
Read more

Naomi Osaka’s statement about withdrawing from French Open

Japan’s Naomi Osaka returns the ball to Romania’s Patricia Maria Tig during their first round match of the French open tennis tournament at the Roland Garros stadium Sunday, May 30, 2021 in Paris. (AP Photo/Christophe Ena) Naomi Osaka tweeted the following statement announcing her withdrawal from the French Open on Monday: “Hey everyone, this isn’t a situation I ever imagined or intended when I posted a few days ago. I think now the best thing for the tournament, the other players and my well-being is that I withdraw so that everyone can get back to focusing on the tennis going on in Paris. ”I never wanted to be a distraction and I accept that my timing was not idea and my message could have been clearer. ”More importantly I would never trivialize mental health or use the term lightly. The truth is that I have suffered long bouts of depression since the US Open in 2018 and I have had a really hard time coping with that. Anyone that knows me knows I’m introverted, and anyone tha...
Post a Comment
Read more

Remdesivir: The COVID-19 drug helping patients recover faster

A vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. PHOTO: AP Remdesivir has been shown to speed up recovery times for patients with COVID-19 in a major US-led trial, becoming the first drug with proven benefit against the disease. Here is what you need to know. – What is remdesivir? – Remdesivir is an experimental, broad spectrum antiviral made by US pharmaceutical Gilead Sciences that was first developed to treat Ebola, a viral hemorrhagic fever. It showed early promise in a primate study in 2016 and was later rolled out for a major trial in the Democratic Republic of Congo, where it was compared against three other medicines. That study concluded in 2019 when it was discontinued because it did not boost survival rates as greatly as two monoclonal antibody drugs, which are lab-engineered immune system proteins. In February, the US National Institute of Allergy and Infectious Diseases (NIAID) announced ...
Post a Comment
Read more